CoChat
Cited by 162

The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.

Regulation of NF‐κB and p53 through activation of ATR and Chk1 by the ARF tumour suppressor

Open access
Rocha, Sonia, Garrett, Michelle D, Campbell, Kirsteen J, Schumm, Katie, Perkins, Neil D · 2005 · The EMBO Journal

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/sj.emboj.7600608

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 36

  1. Abraham RT (2001) Cell cycle checkpoint signaling through the ATM and ATR kinases. Genes Dev 15: 2177–2196 · DOI · Paper page
  2. Bartek J, Lukas J (2003) Chk1 and Chk2 kinases in checkpoint control and cancer. Cancer Cell 3: 421–429 · DOI · Paper page
  3. Bertwistle D, Sugimoto M, Sherr CJ (2004) Physical and functional interactions of the Arf tumor suppressor protein with nucleophosmin/B23. Mol Cell Biol 24: 985–996 · DOI · Paper page
  4. Campbell KJ, Rocha S, Perkins ND (2004) Active repression of antiapoptotic gene expression by ReIA(p65) NF‐κB. Mol Cell 13: 853–865 · DOI · Paper page
  5. de Toledo SM, Azzam EI, Dahlberg WK, Gooding TB, Little JB (2000) ATM complexes with HDM2 and promotes its rapid phosphorylation in a p53‐independent manner in normal and tumor human cells exposed to ionizing radiation. Oncogene 19: 6185–6193 · DOI
  6. Dumaz N, Meek DW (1999) Serine15 phosphorylation stimulates p53 transactivation but does not directly influence interaction with HDM2. EMBO J 18: 7002–7010 · DOI · Paper page
  7. Esteller M (2002) CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future. Oncogene 21: 5427–5440 · DOI · Paper page
  8. Eymin B, Karayan L, Seite P, Brambilla C, Brambilla E, Larsen CJ, Gazzeri S (2001) Human ARF binds E2F1 and inhibits its transcriptional activity. Oncogene 20: 1033–1041 · DOI · Paper page
  9. Fatyol K, Szalay AA (2001) The p14(ARF) tumor suppressor protein facilitates nucleolar sequestration of hypoxia‐inducible factor‐1 α (HIF‐1 α) and inhibits HIF‐1‐mediated transcription. J Biol Chem 276: 28421–28429 · DOI
  10. Foray N, Marot D, Gabriel A, Randrianarison V, Carr AM, Perricaudet M, Ashworth A, Jeggo P (2003) A subset of ATM‐ and ATR‐dependent phosphorylation events requires the BRCA1 protein. EMBO J 22: 2860–2871 · DOI · Paper page
  11. Fujioka S, Schmidt C, Sclabas GM, Li ZK, Pelicano H, Peng B, Yao A, Niu JG, Zhang W, Evans DB, Abbruzzese JL, Huang P, Chiao PJ (2004) Stabilization of p53 is a novel mechanism for proapoptotic function of NF‐κB. J Biol Chem 279: 27549–27559 · DOI
  12. Hammond EM, Dorie MJ, Giaccia AJ (2003) ATR/ATM targets are phosphorylated by ATR in response to hypoxia and ATM in response to reoxygenation. J Biol Chem 278: 12207–12213 · DOI · Paper page
  13. Hutchins JRA, Hughes M, Clarke PR (2000) Substrate specificity determinants of the checkpoint protein kinase Chk1. FEBS Lett 466: 91–95 · DOI
  14. Ishimi Y, Komamura‐Kohno Y, Kwon HJ, Yamada K, Nakanishi M (2003) Identification of MCM4 as a target of the DNA replication block checkpoint system. J Biol Chem 278: 24644–24650 · DOI
  15. Khosravi R, Maya R, Gottlieb T, Oren M, Shiloh Y, Shkedy D (1999) Rapid ATM‐dependent phosphorylation of MDM2 precedes p53 accumulation in response to DNA damage. Proc Natl Acad Sci USA 96: 14973–14977 · DOI · Paper page
  16. Kohn EA, Yoo CJ, Eastman A (2003) The protein kinase c inhibitor Go6976 is a potent inhibitor of DNA damage‐induced S and G(2) cell cycle checkpoints. Cancer Res 63: 31–35
  17. Kuo M, Duncavage EJ, Mathew R, den Besten W, Pei D, Naeve D, Yamamoto T, Cheng C, Sherr CJ, Roussel MF (2003) Arf induces p53‐dependent and ‐independent antiproliferative genes. Cancer Res 63: 1046–1053
  18. Lai JS, Herr W (1992) Ethidium‐bromide provides a simple tool for identifying genuine DNA‐independent protein associations. Proc Natl Acad Sci USA 89: 6958–6962 · DOI · Paper page
  19. Li Y, Wu D, Chen B, Ingram A, He L, Liu L, Zhu D, Kapoor A, Tang D (2004) ATM activity contributes to the tumor‐suppressing functions of p14(ARF). Oncogene 23: 7355–7365 · DOI
  20. Lindstrom MS, Wiman KG (2003) Myc and E2F1 induce p53 through p14ARF‐independent mechanisms in human fibroblasts. Oncogene 22: 4993–5005 · DOI
  21. Llanos S, Clark PA, Rowe J, Peters G (2001) Stabilization of p53 by p14(ARF) without relocation of MDM2 to the nucleolus. Nat Cell Biol 3: 445–452 · DOI · Paper page
  22. Mason SL, Loughran O, La Thangue NB (2002) p14(ARF) regulates E2F activity. Oncogene 21: 4220–4230 · DOI
  23. Michael D, Oren M (2002) The p53 and Mdm2 families in cancer. Curr Opin Genet Dev 12: 53–59 · DOI · Paper page
  24. Perkins ND (2004) NF‐κB: tumor promoter or suppressor? Trends Cell Biol 14: 64–69 · DOI · Paper page
  25. Rocha S, Campbell KJ, Perkins ND (2003) p53‐ and Mdm2‐independent repression of NF‐κB transactivation by the ARF tumor suppressor. Mol Cell 12: 15–25 · DOI · Paper page
  26. Roche KC, Wiechens N, Hughes TO, Perkins ND (2004) The FHA domain protein SNIP1 is a regulator of the cell cycle and cyclin D1 expression. Oncogene 23: 8185–8195 · DOI
  27. Rodway H, Llanos S, Rowe J, Peters G (2004) Stability of nucleolar vs non‐nucleolar forms of human p14(ARF). Oncogene 23: 6186–6192 · DOI
  28. Ryan KM, Ernst MK, Rice NR, Vousden KH (2000) Role of NF‐κB in p53‐mediated programmed cell death. Nature 404: 892–897 · DOI · Paper page
  29. Sherr CJ (2001) The INK4a/ARF network in tumour suppression. Nat Rev Mol Cell Biol 2: 731–737 · DOI · Paper page
  30. Somasundaram K, MacLachlan TK, Burns TF, Sgagias M, Cowan KH, Weber BL, El‐Deiry WS (1999) BRCA1 signals ARF‐dependent stabilization and coactivation of p53. Oncogene 18: 6605–6614 · DOI
  31. Stott FJ, Bates S, James MC, McConnell BB, Starborg M, Brookes S, Palmero I, Ryan K, Hara E, Vousden KH, Peters G (1998) The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2. EMBO J 17: 5001–5014 · DOI · Paper page
  32. Sugimoto M, Kou M, Roussel MF, Sherr CJ (2003) Nucleolar Arf tumor suppressor inhibits ribosomal RNA processing. Mol Cell 11: 415–424 · DOI · Paper page
  33. Tergaonkar V, Pando M, Vafa O, Wahl G, Verma I (2002) p53 stabilization is decreased upon NFκB activation: a role for NFκB in acquisition of resistance to chemotherapy. Cancer Cell 1: 493–503 · DOI · Paper page
  34. Vousden KH (2002) Activation of the p53 tumor suppressor protein. BBBA Rev Cancer 1602: 47–59
  35. Ward IM, Minn K, Chen JJ (2004) UV‐induced ataxia‐telangiectasia‐mutated and Rad3‐related (ATR) activation requires replication stress. J Biol Chem 279: 9677–9680 · DOI · Paper page
  36. Yarden RI, Pardo‐Reoyo S, Sgagias M, Cowan KH, Brody LC (2002) BRCA1 regulates the G2/M checkpoint by activating Chk1 kinase upon DNA damage. Nat Genet 30: 285–289 · DOI · Paper page

Cited by

See all 162

Metadata

Authors
Rocha, S., Garrett, M. D., Campbell, K. J., Schumm, K., & Perkins, N. D.
Venue
The EMBO Journal
Published
2005-03-10
Volume
24
Issue
6
Pages
1157-1169
ISSN
  • 0261-4189 (ISSN-L)
  • 1460-2075
OpenAlex
W2126415922
Cited by
162
References
14
FWCI
8.76
Type
journal article
Language
en
Open access
bronze
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.